The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
Current understanding of the molecular and cellular pathology of diabetic retinopathy
Open accessAbstract
Diabetes mellitus has profound effects on multiple organ systems; however, the loss of vision caused by diabetic retinopathy might be one of the most impactful in a patient’s life. The retina is a highly metabolically active tissue that requires a complex interaction of cells, spanning light sensing photoreceptors to neurons that transfer the electrochemical signal to the brain with support by glia and vascular tissue. Neuronal function depends on a complex inter-dependency of retinal cells that includes the formation of a blood–retinal barrier. This dynamic system is negatively affected by diabetes mellitus, which alters normal cell–cell interactions and leads to profound vascular abnormalities, loss of the blood–retinal barrier and impaired neuronal function. Understanding the normal cell signalling interactions and how they are altered by diabetes mellitus has already led to novel therapies that have improved visual outcomes in many patients. Research highlighted in this Review has led to a new understanding of retinal pathophysiology during diabetes mellitus and has uncovered potential new therapeutic avenues to treat this debilitating disease. This Review focuses on the current understanding of the molecular and cellular pathology of diabetic retinopathy. The primary focus is on the cellular signalling between the neuronal and vascular retina that promotes formation of the inner blood–retinal barrier of the retinal vasculature as an important point of intervention. Diabetic retinopathy is a leading cause of blindness that disrupts the normal interaction of the retinal neural and vascular components leading to vascular permeability, neovascularization and loss of proper neural function. Current effective therapeutic approaches target vascular endothelial growth factor, while a host of new therapies targeting vascular endothelial and pericyte signalling and inflammatory cytokines are being tested for diabetic retinopathy. Stem cell therapy for vascular regeneration holds potential for restorative therapeutic approaches in diabetic retinopathy. Understanding the neuronal and glial changes that drive loss of vision is rapidly emerging, and targeted approaches to directly test the relationship between the neurovascular unit and alteration in diabetic retinopathy are needed. Diabetic retinopathy is a leading cause of blindness that disrupts the normal interaction of the retinal neural and vascular components leading to vascular permeability, neovascularization and loss of proper neural function. Current effective therapeutic approaches target vascular endothelial growth factor, while a host of new therapies targeting vascular endothelial and pericyte signalling and inflammatory cytokines are being tested for diabetic retinopathy. Stem cell therapy for vascular regeneration holds potential for restorative therapeutic approaches in diabetic retinopathy. Understanding the neuronal and glial changes that drive loss of vision is rapidly emerging, and targeted approaches to directly test the relationship between the neurovascular unit and alteration in diabetic retinopathy are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
Ogurtsova, K., da Rocha Fernandes, J. D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N. H., Cavan, D., Shaw, J. E., & Makaroff, L. E. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.024 · Cited by 6,966
Wilkinson, C. P., Ferris, F. L., Klein, R. E., Lee, P. P., Agardh, C. D., Davis, M., Dills, D., Kampik, A., Pararajasegaram, R., & Verdaguer, J. T. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00475-5 · Cited by 3,743
Basic and Therapeutic Aspects of Angiogenesis
Potente, M., Gerhardt, H., & Carmeliet, P. (2011) · Cell · doi:10.1016/j.cell.2011.08.039 · Cited by 2,771
(1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050120030015 · Cited by 2,540
Epigenetic memory in induced pluripotent stem cells
Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee, M. J., Ji, H., Ehrlich, L. I. R., et al. (2010) · Nature · doi:10.1038/nature09342 · Cited by 2,313
Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187
Pericytes are required for blood–brain barrier integrity during embryogenesis
Daneman, R., Zhou, L., Kebede, A. A., & Barres, B. A. (2010) · Nature · doi:10.1038/nature09513 · Cited by 2,128
(1991) · Ophthalmology · doi:10.1016/s0161-6420(13)38012-9 · Cited by 2,048
Split-spectrum amplitude-decorrelation angiography with optical coherence tomography
Jia, Y., Tan, O., Tokayer, J., Potsaid, B., Wang, Y., Liu, J. J., Kraus, M. F., Subhash, H., Fujimoto, J. G., Hornegger, J., et al. (2012) · Optics Express · doi:10.1364/oe.20.004710 · Cited by 1,841
Optical coherence tomography angiography
Spaide, R. F., Fujimoto, J. G., Waheed, N. K., Sadda, S. R., & Staurenghi, G. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.11.003 · Cited by 1,779
Cited by
Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy
Lu, X., Xie, Q., Pan, X., Zhang, R., Zhang, X., Peng, G., Zhang, Y., Shen, S., & Tong, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01951-9 · Cited by 665
Goncalves, A., & Antonetti, D. A. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00386-0 · Cited by 22
Self-citation
Metadata
- Authors
- Antonetti, D. A., Silva, P. S., & Stitt, A. W.
- Venue
- Nature Reviews Endocrinology
- Published
- 2021-01-19
- Volume
- 17
- Issue
- 4
- Pages
- 195-206
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W3121608322
- Cited by
- 645
- References
- 152
- FWCI
- 22.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Current understanding of the molecular and cellular pathology of diabetic retinopathy. https://app.cochat.ai/papers/10.1038/s41574-020-00451-4
- The paper
- Antonetti, D. A., Silva, P. S., & Stitt, A. W. (2021). Current understanding of the molecular and cellular pathology of diabetic retinopathy. Nature Reviews Endocrinology. https://doi.org/10.1038/s41574-020-00451-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.